← Back to Max Healthcare Institute Ltd. overview
Max Healthcare Institute Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹6,910 cr | ₹1,076 cr | ₹11.01 | ₹15,214 cr | ₹9,381 cr | 11.47% | 12.55% | 0.32x | 15.57% |
| FY2024 | ₹5,309 cr | ₹1,058 cr | ₹10.84 | ₹12,000 cr | ₹8,408 cr | 12.58% | 14.53% | 0.15x | 19.92% |
| FY2023 | ₹4,489 cr | ₹1,104 cr | ₹11.36 | ₹10,102 cr | ₹7,410 cr | 14.89% | 13.65% | 0.12x | 24.58% |
| FY2022 | ₹3,883 cr | ₹605 cr | ₹6.24 | ₹9,189 cr | ₹6,282 cr | 9.63% | 11.17% | 0.18x | 15.58% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.